Patents Assigned to Vasgene Theapeutics, Inc
  • Polypeptide compounds for inhibiting angiogenesis and tumor growth
    Patent number: 8981062
    Abstract: In certain embodiments, this present invention provides polypeptide compositions (e.g., antibodies and antigen binding portions thereof that bind to EphB4), and methods for inhibiting EphB4 activity. In other embodiments, the present invention provides methods and compositions for treating cancer or for treating angiogenesis-associated diseases.
    Type: Grant
    Filed: June 6, 2011
    Date of Patent: March 17, 2015
    Assignee: Vasgene Theapeutics, Inc
    Inventors: Valery Krasnoperov, Nathalie Kertesz, Ramachandra Reddy, Parkash Gill, Sergey Zozulya